The multispeciality approach to the management of localised kidney cancer
Details
Publication Year 2022-08,Volume 400,Issue #10351,Page 523-534
Journal Title
Lancet
Publication Type
Review
Abstract
Historically, kidney cancer was approached in a siloed single-speciality way, with urological surgeons managing the localised stages of the disease and medical oncologists caring for patients if metastases developed. However, improvements in the management of localised kidney cancer have occurred rapidly over the past two decades with greater understanding of the disease biology, diagnostic options, and innovations in curative treatments. These developments are favourable for patients but provide a substantially more complex landscape for patients and clinicians to navigate, with associated challenging decisions about who to treat, how, and when. As such, the skill sets needed to manage the various aspects of the disease and guide patients appropriately outstrips the capabilities of one particular specialist, and the evolution of a multispeciality approach to the management of kidney cancer is now essential. In this Review, we summarise the current best multispeciality practice for the management of localised kidney cancer and the areas in need of further research and development.
Keywords
Humans; *Kidney Neoplasms/diagnosis/surgery
Department(s)
Radiation Oncology
PubMed ID
35868329
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-04-11 03:02:46
Last Modified: 2025-04-11 03:05:16

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙